Altogether, these findings suggest that reducing levels of FHR-4 at the RPE/Bruch’s membrane/choroid interface may lead to enhanced AP regulation by FH/FHL-1 and delay or prevent AMD initiation and/or progression. The gene discussed is FHL1; the disease is age-related macular degeneration.